Delivery Order SPE2DR25D3005-SPE2DR26FP8BJ
- Not listed
- The Defense Logistics Agency awarded a $2,869.43 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $36,599.31 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on November 3, 2025, with completion targeted for November 4, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical will be delivered to the contractor's primary location in...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a $13,614.27 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 10, 2025, with completion scheduled for December 11, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The award will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,441.71 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $107,953.28 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under firm fixed price terms. This non-competitive delivery order, issued on October 30, 2025, with completion expected by October 31, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,578.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) under a firm fixed price contract. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order typical of the agency's pharmaceutical procurement activities. This delivery...
- The Defense Logistics Agency awarded a $19,742.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8BJDelivery Order
The Defense Logistics Agency awarded a $54,397.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 8-count packages of NURTEC ODT 75 mg tablets. This non-set-aside competitive award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a pharmaceutical supply delivery under the company's broader federal contract portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive portfolio of neurological and specialty pharmaceutical products delivered through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.4k | 12/14/25 |